AnaptysBio Shares Plunge After Announcing Phase 2B Trial in Atopic Dermatitis Failed to Meet Endpoints
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.08 USD | +0.12% |
|
-7.69% | +21.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration